Raymond James Financial’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9M Sell
39,364
-18,190
-32% -$7.79M ﹤0.01% 1692
2025
Q4
$24.6M Sell
57,554
-13,698
-19% -$5.96M 0.01% 1296
2025
Q3
$31.9M Sell
71,252
-4,902
-6% -$2.22M 0.01% 1094
2025
Q2
$37.1M Sell
76,154
-118
-0.2% -$67.2K 0.01% 945
2025
Q1
$46.9M Sell
76,272
-3,047
-4% -$1.73M 0.02% 755
2024
Q4
$42M Buy
+79,319
New +$44.7M 0.02% 828

Other funds holding CHE

Raymond James Financial's CHE Position: Q1 2026 in Review

Raymond James Financial reduced its Chemed (CHE) stake by 32% in Q1 2026, selling an estimated $7.79M and leaving 39,364 shares worth $14.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1692.

Raymond James Financial first reported a position in CHE in Q4 2024 and has held it in 6 quarters since. The position peaked at $46.9M in Q1 2025. 488 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Raymond James Financial held 39,364 shares of Chemed worth $14.9M as of Q1 2026.
  • Raymond James Financial sold 18,190 Chemed shares in Q1 2026, an estimated $7.79M.
  • Chemed made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #1692 holding.
  • Raymond James Financial first reported a position in Chemed in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Chemed position peaked at $46.9M in Q1 2025.
  • 488 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.